A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines.
Feola S, Chiaro J, Martins B, Russo S, Fusciello M, Ylösmäki E, Bonini C, Ruggiero E, Hamdan F, Feodoroff M, Antignani G, Viitala T, Pesonen S, Grönholm M, Branca RMM, Lehtiö J, Cerullo V.
Feola S, et al. Among authors: branca rmm.
Elife. 2022 Mar 22;11:e71156. doi: 10.7554/eLife.71156.
Elife. 2022.
PMID: 35314027
Free PMC article.